Lipofundin Mst/Lst

Lipofundin MCT/LST: Fat emulsion for parenteral nutrition

Lipofundin MCT/LST is a pharmaceutical product intended for parenteral nutrition. This is a fat emulsion produced by B. Braun Melsungen AG in Germany. It is presented in two dosage forms: emulsion for infusion 10% and emulsion for infusion 20%.

The main components of Lipofundin MCT/LST are soybean oil, soybean phosphatide and glycerin. These ingredients provide energy support and essential fatty acids for the body. Fat emulsions are an important part of parenteral nutrition, especially for patients who are unable to obtain sufficient nutrition through the gastrointestinal tract.

Lipofundin MCT/LST is recommended for use in the following cases: diseases of the digestive tract, unconsciousness, fasting in the preoperative and postoperative period lasting more than 3 days, chronic renal failure, burns and severe infections. It can be used in hospital settings and should be prescribed and supervised by qualified medical personnel.

According to the literature, there is no information on contraindications, side effects and interactions of Lipofundin MCT/LST with other drugs. There are also no data available regarding overdose. However, it should be noted that the emulsion should not be mixed with other drugs.

Particular attention should be paid to the fact that Lipofundin MCT/LST is used only in a hospital setting. This is due to the need to monitor and monitor the patient during emulsion infusion.

It should be noted that the data provided is based on information from the reference book "Medicines" edited by Klyuev M.A., published in 2001. In this regard, for more up-to-date information and recommendations, it is recommended to consult a medical specialist or refer to more up-to-date sources.